Clinical Trial Update: A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan

View source ↗

Summary

This completed study investigates the prevalence of HER2 IHC 3+ and characterizes clinicopathologic features of gynecologic cancers in Taiwan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer

Snippet

Sponsor: Daiichi Sankyo | Conditions: Cervical Cancers, Endometrial Cancer | Status: COMPLETED